more important. Uraemia has a significant eÂect on the intestinal absorption and compartmentalization of Background. Developments in accelerator mass spectrometry (AMS) now permit the determination of aluminium. It enhances fractional absorption and increases subsequent extracellular deposition of alumifemtogram amounts of 26Al in blood and in various tissues with good precision and free of external nium in bone. However, at the same time uraemia does not increase transferrin-dependent cellular accucontamination. Methods. In the present study we used trace quantities mulation of aluminium in liver and spleen. of 26Al to investigate the intestinal absorption and compartmentalization of aluminium in rats with renal Key words: aluminium; 26Al tracer; intestinal absorpfailure (Nx, 5/6 nephrectomy) and in pair-fed controls tion; compartmentalization; uraemia; accelerator mass (C ). Single oral doses of 20 ng 26Al were administered spectrometry to six animals in each group and, subsequently, 24-h post-load 26Al was analysed in serum, urine, bone, liver, and spleen by means of AMS.
Results. Serum concentrations of 26Al were signific-Introduction antly lower in uraemic rats compared to controls, whereas urinary excretion was comparable (Nx, Although aluminium intoxication in patients with 7.11±5.78 pg/day vs C, 9.46±6.10 pg/day), suggesting chronic renal failure has been recognized as being a higher fraction of ultrafiltrable serum 26Al in involved in the pathogenesis of several clinical disuraemia. The target tissues of cellular transferrin-orders including dialysis dementia, vitamin D-resistant mediated 26Al uptake, liver and sleen, tended to show adynamic bone disease and hypochromic microcytic a larger degree of aluminium accumulation in con-anaemia, our knowledge about its toxicokinetics is still trols (0.26±0.31 pg/g vs Nx, 0.14±0.10 pg/g and limited [1] [2] [3] . This lack of a solid data base is largely 0.37±0.27 pg/g vs Nx, 0.25±0.27 pg/g respectively). related to the fact that available methods for the In contrast, in bone, a site of extracellular aluminium determination of aluminium in serum or tissues, such deposition, 26Al concentrations were more elevated in as flameless atomic absorptiometry, have only limited uraemia (1.22±0.59 pg/g vs C: 0.68±0.30 pg/g). sensitivity and are hampered by preanalytical errors Estimated total 26Al accumulation in all measured due to contamination. This problem gains even more target tissues was significantly higher in uraemic rats importance since despite today's adequate purification ( 28.15±9.90 pg vs C: 17.03±7.03 pg) and total recov-of the water used in the dialysis process, some moderate ery of 26Al from tissue and urine was 26.58±6.74 pg degree of aluminium accumulation resulting in subtle in controls and 35.75±7.03 pg in uraemic animals, or overt toxicity may persist in a certain number of suggesting a fractional absorption of 0.133% and dialysis patients. This residual aluminium burden is 0.175% respectively.
derived from intestinal absorption from low doses of Conclusions. Our data suggest that fractional absorp-aluminium-containing phosphate binders and from tion from a dietary level dose of 26Al is about 0.13%. other dietary sources [3] [4] [5] [6] . In addition, several Compartmentalization occurs in transferrin-dependent episodes of acute aluminium intoxication have drawn target tissues such as liver and spleen; however, in attention to the fact that aluminium toxicity will still quantitative terms extracellular deposition in bone is have to be considered in the future [7, 8] .
Recently, measurement of the isotope 26Al by accelerator mass spectrometry (AMS) has been introduced 27Al was added as a carrier. For urine samples 50 mg 27Al to explore the metabolism of aluminium at physiologias AlCl 3 was added. Samples were dried at 90°C and then cal levels of exposure [9 ] . AMS can detect the long- and the application of the exquisite sensitivity of this
The actual detection limit for the isotope ratio 26Al/27Al was technique has to be focused on carefully selected 7×10−16 [ 20] . The measured 26Al/27Al ratios of samples of projects. Despite these limitations several pioneering rats where 26Al was administered were in the range of 10−13 studies have recently succeeded in studying the kinetics to 5×10−12, typically several times 10−13. 26Al/27Al ratios of 26Al in several experimental animal models and in of blank samples of rats where 26Al was not administered humans [9] [10] [11] [12] [13] [14] .
were in the range of <5×10−14. [ 15] . Renal failure rats were rendered between two parameters was accomplished by the Spearman uraemic by a two-stage 5/6 nephrectomy (Nx) [ 16 ] . rank correlation coeÃcient. Subsequently, all animals had free access to distilled water, but uraemic rats and controls matched for weight were pair-fed.
Results
Four weeks after the second operation residual renal function was determined and all rats were studied by a single oral load of 26Al in one of two separate experimental series Serum chemistry and other parameters of interest in according to a well-established protocol [16] [17] [18] . Seventy-uraemic rats and in pair-fed controls are shown in two hours prior to aluminium ingestion rats were placed in Table 1 . There were no diÂerences with respect to iron individual metabolic cages. Forty hours later food was with-concentration in the liver between both groups. drawn but access to deionized drinking water was permitted Although there was a tendency for serum phosphate until 1 h prior to the aluminium load. Each rat received a and PTH to be elevated and for serum calcium to be following the aluminium load urine was collected for 24 h. tissues or serum or urine. Twenty-four hours after Water was returned 3 h after administration of aluminium. administration of the aluminium isotope AMS was Food was withheld during the subsequent 24 post-load hours able to measure femtogram amounts in all tissues and to prevent fecal contamination of urine. In the first experi-body fluids obtained ( Table 2 ). In the target tissues of mental series six uraemic rats and an equal number of pair-cellular transferrin-mediated 26Al uptake, liver and fed controls were sacrificed 24 h after the oral dosing and spleen, aluminium tended to be more elevated in blood, liver, spleen, and bone were harvested. In the second controls although the overall diÂerences were not set of experiments serial blood samples were obtained at significant. When both groups were considered together hours 2 and 5 in one uraemic rat and in a respective control.
spleen aluminium concentration was significantly Five millilitres of serum or urine were used for the preparahigher as compared to liver 26Al ( 0.31±0.26 pg/g vs tion of samples for analysis by AMS as desribed previously [ 12, 13] . Briefly, serum was digested with trypsin and 5 mg 0.20±0.23 pg/g, P<0.05). The increase in bone 26Al, Table 1 . Body weight, serum chemistry, and liver iron in uraemic rats and in pair-fed controls studied with a single oral dose of 26Al a site of extracellular aluminium deposition, was significantly larger in uraemic rats as compared to controls and urinary excretion of aluminium tended to be lower. Surprisingly, serum concentrations of 26Al were significantly lower in uraemic rats ( 9.39±7.83 pg/l ) as ( Figure 1 ). There was higher in uraemic rats as compared to controls no correlation between serum 26Al concentration and (Figure 3 ). In uraemic rats there was also a tendency the amount of isotope detected in liver tissue in both for a correlation between serum creatinine and bone groups ( Figure 2 ). However, there was a tendency for 26Al suggesting that the more compromised renal funcan inverse correlation between bone aluminium and tion was the more aluminium was deposited in bone serum aluminium (rho=0.55, P=0.07) and for almost (rho=0.77, P=0.08). There was no clear-cut correlation between the amount of aluminium detected in the Fig. 1 . Fraction of orally administered 26Al deposited in liver and Fig. 3 . Relationship between serum aluminium concentration and bone 24 h after an oral aluminium load in uraemic rats (n=6) and controls (n=6) (mean value±1 standard error (SE) of the mean). the concentration of 26Al deposited in bone 24 h after an oral aluminium load in uraemic rats (n=6 ) and in controls (n=6). *P<0.05 vs control.
known about whether this pattern of tissue deposition would also apply to physiological aluminium metabolism, since in individuals with normal renal function, tissue aluminium levels do not increase with age [1, 24] . Furthermore, increases in tissue aluminium following a single oral load are far too small to be reliably detected by conventional analytical technology. Subsequent experimental studies suggested that in rats similar to humans the highest concentrations of aluminium are found in bone, spleen, and liver [2 ] . However, again these data were generated under somewhat artifical conditions, or interpretation was diÃcult because of methodological problems. Following intraperitoneal administration of aluminium lactate, tissue aluminium concentrations were highest in spleen fol- Fig. 4 . Fraction of orally administered 26Al recovered from liver, lowed by liver tissue [25] . Surprisingly, aluminium spleen, and bone (tissue), recovered from urinary excretion over 24 h, and total recovery combined from both sources (mean value±1 concentrations in bone were considerably lower, which SE). *P<0.05 vs control.
was at odds with previous findings in patients receiving an undesired aluminium load during haemodialysis urine on the one hand versus the amount of 26Al [1, 24] . In a similar study employing intraperitoneal deposited in tibial bone on the other hand in uraemic injections of aluminium chloride, liver aluminium was rats (rho=0.50, P=0.31 respectively).
again twice as high compared with bone aluminium Estimated total 26Al accumulation in all measured concentrations; however, it remains an open question target tissues was significantly higher in uraemic rats whether the route of administration favoured an ( 28.15±9.90 pg (fraction of 26Al administered, excessive increase in portal blood aluminium concen-14.1×10−4 ) vs controls, 17.03±7.03 pg (8.5×10−4), trations that may not reflect usual toxicokinetics [26 ] . P<0.05) ( Figure 4 ). Both in uraemics and in controls In contrast, rats dosed with aluminium orally were bone aluminium was larger than recovery of aluminium reported to accumulate aluminium predominantly in from 24 h urine ( Figure 1, Figure 4 ). Total recovery of bone, but the absolute increases in tissue aluminium 26Al from tissue and urine was 26.58±6.74 pg in were in a low range and are therefore subject to many controls and 35.75±7.03 pg in uraemic animals analytical errors [27, 28] . Finally, surrogate isotopes (P<0.05), suggesting a fractional absorption from for aluminium kinetics such as 67Ga were found to be intestine of 0.133% and 0.175% respectively ( Figure 4) . of limited value to assess the compartmentalization of In the second experiment early serum kinetics of aluminium [28 ] . 26Al were studied in an uraemic rat with a comparable
The data of the present study provide some clarifying degree of renal failure (serum creatinine: 103 mmol/l ) insights into compartmentalization and tissue retention and a similar body weight (241 g). One pair-fed control of aluminium in the dose range of a dietary level. Prior was dosed in parallel. Two hours after oral administra-to administration of the 26Al tracer we were unable to tion of 26Al, serum concentration was higher in the detect any 26Al in all biomaterials analysed, suggesting uraemic animal as compared to the control (94 pg/l vs that our results were not confounded by contamina-46 pg/l ). After 5 h, however, 26Al serum concentrations tion. Twenty-four hours after ingestion of the tracer, were 16 pg/l and 30 pg/l respectively. significant amounts of 26Al could be detected in both liver and spleen tissue, but spleen aluminium concentrations were significantly more elevated when uraemic Discussion rats and controls were considered together. In both target tissues cellular accumulation of aluminium has been shown to occur via receptor-mediated interThe extreme sensitivity of AMS for long-lived isotopes such as 26Al makes it a powerful tool in biomedical nalization of transferrin-bound aluminium [29 ] .
Transferrin-mediated aluminium uptake has been demresearch. The present study demonstrates that the 26Al tracer measured by AMS can be used to address several onstrated in hepatocytes and in lymphocytes and it is also likely to occur in macrophages [30] [31] [32] . In liver hitherto conflicting issues: (a) precise quantification of the fractional intestinal absorption of aluminium at cells aluminium could be demonstrated in cytoplasm and various organelles following intravenous adminisphysiological levels of exposure; (b ) assessment of transferrin-dependent compartmentalization versus tration [33] . The present study did not assess the respective roles of these cells for tissue uptake of extracellular deposition in various target tissues; (c) delineation of the eÂect of uraemia on both fractional aluminium; however, our data indicate possible preferential uptake by lymphocytes or macrophages, since absorption and compartmentalization.
Earlier studies in uraemic patients already suggested spleen aluminium concentration was 1.5-fold higher
would explain earlier preliminary 26Al data suggesting uraemia and aluminium mobilization following renal allografting may reduce the incidence of graft rejec-a greater 'aÃnity for aluminium' of uraemic bone [42 ] .
Alternatively, it cannot be excluded that the uraemic tion [34, 35] .
Whereas transferrin-mediated accumulation of alu-state might have decreased aluminium binding to serum proteins. This phenomenon has been suggested by minium represents an interesting mechanism of toxicity, our 26Al tracer data clearly show that even at a several investigators but has never been convincingly confirmed by others [2, 43] . Although serum aluminium low level of exposure the major compartment of tissue retention is bone. Our findings are in line with recent concentrations were more elevated in uraemia 2 h after the tracer load, this does not explain higher bone 26Al tracer studies in rats suggesting that approximately 50% of the absorbed aluminium is excreted in the urine aluminium deposition, since post-load serum aluminium after 5 and 24 h was actually significantly lower over 5 days and the remainder is largely retained in bone [10, 36 ] . In the present study 60% of the absorbed compared to controls, again suggesting increased avidity for bone deposition. Rather, this early larger fraction was detected in tibial bone and 35% in urine after just 24 h. Since bone is a site of predominant increase in serum 26Al in uraemia is related to enhanced paracellular absorption, and this finding compares well extracellular deposition of aluminium and since renal excretion, too, stems from ultrafiltrable non-protein-with the eÂect of dietary citrate, which has also been shown to increase the absorption of aluminium via the bound aluminium, these data indicate that excretion and compartmentalization are mainly determined by paracellular pathway [36, 44] .
Interpreting the present data it has to be acknowtransferrin-independent pathways. Reported data regarding the size of the ultrafiltrable fraction of alumi-ledged that the small sample size and the moderate degree of renal failure impose some limitations. Thus, nium in serum vary considerably but it may be around 5-20% and there are several possible constituents of based on previously published data [16 ] , it seems possible that a longer duration and a more severe the small-molecule complexes in serum such as citrate or silicate [2, [37] [38] [39] [40] [41] . Furthermore, it is unknown degree of uraemia could have revealed a more profound eÂect on aluminium metabolism. whether aluminium is absorbed paracellularly from the intestine as a small-molecule complex or whether Fractional absorption of aluminium from the intestine has been diÃcult to determine in the past [3] . The absorption occurs as a transcellular process and protein-bound aluminium in the portal blood equilibrates best estimates using conventional techniques were derived from the post-load measurement of urinary thereafter with complexing ligands [3, 38] . Recent experiments from our laboratory would suggest that aluminium excretion over several days, suggesting an absorbed fraction of 0.06% in the presence of normal apart from the presence of complexing constituents in the diet, the uraemic state is an important determinant renal function and enhanced fractional absorption of 0.2% or more in uraemia [15] [16] [17] [18] . However, it was of either possible pathway [23] . In rats with normal renal function, blockade of the paracellular pathway likely that these estimates were confounded by tissue retention of aluminium and these approaches did not did not reduce fractional absorption of aluminium in the absence of dietary citrate, whereas in uraemia a allow the determination of the degree of aluminium absorption at low levels of exposure with certainty. substantial amount of aluminium was absorbed via the paracellular pathway. The data of the present study The present study clarifies this issue. Total recovery of 26Al from tissue and urine was 26.58±6.74 pg in are in line with this notion since uraemia had a significant eÂect on both the absorbed fraction as well controls and 35.75±7.03 pg in uraemic animals, suggesting a fractional absorption from intestine of 0.133% as on the compartmentalization of aluminium. The target tissues of cellular transferrin-mediated 26Al and 0.175% respectively. These figures confirm earlier estimates of aluminium absorption and are in line with uptake, liver and spleen, tended to show a lower degree of aluminium accumulation in uraemic rats. However, recent 26Al studies addressing the eÂect of citrate [15] [16] [17] [18] 36 ] . In addition, these figures confirm enhanced the overall diÂerences were not significant and the relationship between serum aluminium concentration absorption of aluminium in uraemia which has been a consistent phenomenon in earlier studies using pharmaand the concentration of 26Al deposited in liver tissue was similar in uraemic rats and in controls. In contrast, cological doses of aluminium and extend this finding to low levels of exposure [15] [16] [17] [18] . The present study in bone, a site of extracellular aluminium deposition, 26Al concentrations were significantly more elevated in makes also clear that investigations that restrict measurements to serum and urine aluminium will underestiuraemia. Moreover, for any given serum aluminium concentration bone aluminium tended to be larger in mate the absorbed aluminium fraction, since uraemia favours deposition of aluminium in bone. For the same uraemic animals as compared to controls. Considering our recent finding of increased paracellular intestinal reason data of 26Al studies in humans that rely on just one or a few measurements of serum aluminium should permeability in uraemia these data are compatible with the hypothesis that enhanced absorption of small-be interpreted with some caution [11, 45] . In contrast, safe estimates of the fractional absorption can be molecule complex-bound aluminium resulted in increased extracellular deposition in bone. This would obtained by summing up 26Al contents of urine, serum, 17. Ittel TH, Griessner A, Sieberth HG. EÂect of lactate on the bone, and scaled liver or spleen values, which is in line absorption and retention of aluminum in the remnant kidney with a pharmacokinetic model derived from 26Al tracer rat model. Nephron 1991; 57: 332-339 studies in humans [13, 20] . 
